Exosens markets
See all
Defense & Surveillance
Des solutions innovantes et de haute qualité, conçues pour répondre aux exigences des secteurs de la défense et de la surveillance.
Life Sciences & Environment
Imaging and detection solutions bring high image quality or low-level detection to enabling Life Sciences breakthroughs.
Industrial Control
Exosens Technology providing innovative solutions that take control and non-destructive testing to a whole new level.
Nuclear
Nuclear instrumentation is essential to ensure safety, accuracy, and compliance in various nuclear-related activities.
What's new?
See all
Jul 28th 2026
H1 2026 Exosens Results
Exosens delivers strong performance in H1 2026, driven by sustained momentum in night vision and accelerating demand in defense imaging
Aug 31st 2026
Optical System Alignment
The Lens Was Assembled Correctly, So Why Does the MTF Test Fail?
Aug 25th 2026
Photonis Defense awarded BINOD order
Photonis Defense awarded first delivery order for U.S. Army’s BINOD program, marking a key milestone in Exosens’ U.S. expansion
Our company
Global leader in amplification, detection and imaging technologies
Exosens is a high-tech company, with more than 85 years of experience in the innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. Today, it offers its customers detection components and solutions such as advanced cameras, neutron and gamma detectors, instrument detectors and light intensifier tubes. This allows Exosens to respond to complex issues in extremely demanding environments by offering tailor-made solutions to its customers. Thanks to its sustained investments, Exosens is internationally recognized as a major innovator in optoelectronics, with production and R&D carried out on 12 sites, in Europe and North America, and with over 2,000 employees.
Exosens is listed on compartment A of Euronext Paris regulated market (Ticker: EXENS; ISIN: FR001400Q9V2). Exosens is a member of Euronext Tech Leaders segment and is also included in several indices, including SBF 120, CAC All-Tradable, CAC Mid 60, FTSE Total Cap and MSCI France Small Cap.
85+ years of experience
+2000 Employees
+300 Proven technology patents
+70 countries: 93% revenue outside France
7.6% of revenue invested in gross R&D
468.2M€ Total revenue